55 research outputs found
Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort
Get PDF
Lecture by Peter Selz, given at Florida International University, January 15, 1988
No full textPeter Selz\u27s lecture is about Cobra, beginning with what let to the development of the group, the years during which it existed and the outcomes of the group.
Introduction by Dahlia Morgan
Theories and Documents of Contemporary Art : A Sourcebook of Artists' Writings
No full text"[M]ore than three hundred artists speaking for themselves on issues related to the production and philosophy of contemporary art - has now been updated, revised, and expanded by editor Kristine Stiles to represent thirty countries and more than one hundred new artists" -- p. [4] of cover
Alain Gerbault: Vertical Chamber : 115 Feet High
No full textPurpose: To determine the effect of formoterol and salbutamol on the arterial oxygen saturation (SaO2) of highly trained nonasthmatic athletes with exercise-induced arterial hypoxemia (EIAH). Methods: Ten male athletes (age = 27.1 ± 0.7, V̇O2max = 65.2 ± 2.5 mL·kg-1, min-1, SaO2min = 91.0 ± 2.1%) with minimal bronchial reactivity to aerosols (i.e., negative methacholine challenge test) completed three identical exercise sessions differing only by the medication administered. Formoterol (F), a long-acting β-2 agonist, was compared with salbutamol (S) and a placebo (P). F (12 μg), S (400 μg), or P was administered by a Turbuhaler, 10 min before exercise testing in a double-blind, randomized, three-way crossover design. Testing sessions included an incremental cycle ergometer test to exhaustion, while monitoring SaO2 and ventilation, and a pre- and postexercise pulmonary function test. Results: There were no significant differences between the groups in SaO2 nadir with exercise (F = 92.0 ± 1.0; S = 92.0 ± 1.0; P = 91.0 ± 0.7%). During the maximal incremental test, no differences were observed in SaO2 or minute ventilation between the three experimental conditions. Pulmonary function tests revealed a significant increase in FEV1 and FEV1/FVC after exercise in all conditions. Drug administration increased FEV1/FVC postexercise compared with placebo (F = 87.9 ± 2.3, S = 87.6 ± 1.7 > P = 85.6 ± 2.1%; P 2 nadir or ventilation kinetics in a group of highly trained nonasthmatic athletes with EIAH.</p
- …
